Next-generation sequencing and comparative analysis of sequential outbreaks caused by multidrug-resistant Acinetobacter baumannii at a large academic burn center

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 3, 2016, Pages 1249-1257

  Kanamori, Hajime ^a,b   Parobek, Christian M ^a,b   Weber, David J ^a,b,c   Duin, David Van ^a   Rutala, William A ^a,b   Cairns, Bruce A ^a,b   Juliano, Jonathan J ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; SULTAMICILLIN; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE OXA-23, ACINETOBACTER BAUMANNII;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BURN; NEXT GENERATION SEQUENCING; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; BURN UNIT; CHILD; COMPARATIVE STUDY; COMPLICATION; DRUG EFFECTS; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; NORTH CAROLINA; PATHOGENICITY; RETROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BETA-LACTAMASES; BURN UNITS; BURNS; CHILD; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MIDDLE AGED; NORTH CAROLINA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84960145905     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02014-15     Document Type: Article

References (55)

1. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK, Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. 2014. Multistate point-prevalence survey of health careassociated infections. N Engl J Med 370:1198-1208. http://dx.doi.org/10.1056/NEJMoa1306801.
2. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S, National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities. 2013. Antimicrobialresistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 34:1-14. http://dx.doi.org/10.1086/668770.
3. Yali G, Jing C, Chunjiang L, Cheng Z, Xiaoqiang L, Yizhi P. 2014. Comparison of pathogens and antibiotic resistance of burn patients in the burn ICU or in the common burn ward. Burns 40:402-407. http://dx.doi.org/10.1016/j.burns.2013.07.010.
4. Rezaei E, Safari H, Naderinasab M, Aliakbarian H. 2011. Common pathogens in burn wound and changes in their drug sensitivity. Burns 37:805-807. http://dx.doi.org/10.1016/j.burns.2011.01.019.
5. Falagas ME, Karveli EA. 2007. The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications. Clin Microbiol Infect 13:117-119. http://dx.doi.org/10.1111/j.1469-0691.2006.01596.x.
6. Young LS, Sabel AL, Price CS. 2007. Epidemiologic, clinical, and economic evaluation ofanoutbreakofclonal multidrug-resistantAcinetobacter baumannii infection in a surgical intensive care unit. Infect Control Hosp Epidemiol 28:1247-1254. http://dx.doi.org/10.1086/521660.
7. Markogiannakis A, Fildisis G, Tsiplakou S, Ikonomidis A, Koutsoukou A, Pournaras S, Manolis EN, Baltopoulos G, Tsakris A. 2008. Crosstransmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit. Infect Control Hosp Epidemiol 29:410-417. http://dx.doi.org/10.1086/533545.
8. McGrath EJ, Chopra T, Abdel-Haq N, Preney K, Koo W, Asmar BI, Kaye KS. 2011. An outbreak of carbapenem-resistant Acinetobacter baumannii infection in a neonatal intensive care unit: investigation and control. Infect Control Hosp Epidemiol 32:34-41. http://dx.doi.org/10.1086/657669.
9. Zarrilli R, Pournaras S, Giannouli M, Tsakris A. 2013. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 41:11-19. http://dx.doi.org/10.1016/j.ijantimicag.2012.09.008.
10. Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, Cosgrove SE, Anderson A, Carnell J, Jernigan DB, Kleinbaum DG, Perl TM, Standiford HC, Srinivasan A. 2007. Multidrug-resistant Acinetobacterinfection mortality rate and lengthof hospitalization. Emerg Infect Dis 13:97-103. http://dx.doi.org/10.3201/eid1301.060716.
11. Davis MA, Hancock DD, Besser TE, Call DR. 2003. Evaluation of pulsed-field gel electrophoresis as a tool for determining the degree of genetic relatedness between strains of Escherichia coli O157:H7. J Clin Microbiol 41:1843-1849. http://dx.doi.org/10.1128/JCM.41.5.1843-1849.2003.
12. Johnson JK, Arduino SM, Stine OC, Johnson JA, Harris AD. 2007. Multilocus sequence typing compared to pulsed-field gel electrophoresis for molecular typing of Pseudomonas aeruginosa. J Clin Microbiol 45:3707-3712. http://dx.doi.org/10.1128/JCM.00560-07.
13. Salipante SJ, SenGupta DJ, Cummings LA, Land TA, Hoogestraat DR, Cookson BT. 2015. Application of whole-genome sequencing for bacterial strain typing in molecular epidemiology. J Clin Microbiol 53:1072-1079. http://dx.doi.org/10.1128/JCM.03385-14.
14. Barrick JE, Yu DS, Yoon SH, Jeong H, Oh TK, Schneider D, Lenski RE, Kim JF. 2009. Genome evolution and adaptation in a long-term experiment with Escherichia coli. Nature 461:1243-1247. http://dx.doi.org/10.1038/nature08480.
15. Lewis T, Loman NJ, Bingle L, Jumaa P, Weinstock GM, Mortiboy D, Pallen MJ. 2010. High-throughput whole-genome sequencing to dissect the epidemiology of Acinetobacter baumannii isolates from a hospital outbreak. J Hosp Infect 75:37-41. http://dx.doi.org/10.1016/j.jhin. 2010.01.012.
16. Alvargonzalez JJ, Vindel Hernando A, Martín MD, Casas CM, Iglesias JO, Marín MF, Alvarez ML, Sanchez VB, Marí JM. 2014. Sequential outbreaks in a Spanish hospital caused by multiresistant OXA-58-producingAcinetobacter baumanniiST92. JMed Microbiol 63:1093-1098. http://dx.doi.org/10.1099/jmm.0.067280-0.
17. Ansaldi F, Canepa P, Bassetti M, Zancolli M, Molinari MP, Talamini A, Ginocchio F, Durando P, Mussap M, Orengo G, Viscoli C, Icardi G. 2011. Sequential outbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation. J Hosp Infect 79:134-140. http://dx.doi.org/10.1016/j.jhin. 2011.05.027.
18. Barnaud G, Zihoune N, Ricard JD, Hippeaux MC, Eveillard M, Dreyfuss D, Branger C. 2010. Two sequential outbreaks caused by multidrugresistant Acinetobacter baumannii isolates producing OXA-58 or OXA-72 oxacillinase in an intensive care unit in France. J Hosp Infect 76:358-360. http://dx.doi.org/10.1016/j.jhin. 2010.05.026.
19. Shelburne SA, III, Singh KV, White AC, Jr, Byrne L, Carmer A, Austin C, Graviss E, Stager C, Murray BE, Atmar RL. 2008. Sequential outbreaks of infections by distinct Acinetobacter baumannii strains in a public teaching hospital in Houston, Texas. J Clin Microbiol 46:198-205. http://dx.doi.org/10.1128/JCM.01459-07.
20. Al Naiemi N, Duim B, Savelkoul PHM, Spanjaard L, de Jonge E, Bart A, Vandenbroucke-Grauls CM, de Jong MD. 2005. Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol 43:4862-4864. http://dx.doi.org/10.1128/JCM.43.9.4862-4864.2005.
21. Zarrilli R, Crispino M, Bagattini M, Barretta E, Di Popolo A, Triassi M, Villari P. 2004. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J Clin Microbiol 42:946-953. http://dx.doi.org/10.1128/JCM.42.3.946-953.2004.
22. Corbella X, Montero A, Pujol M, Domínguez MA, Ayats J, Argerich MJ, Garrigosa F, Ariza J, Gudiol F. 2000. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 38:4086-4095.
23. Centers for Disease Control and Prevention, National Healthcare Safety Network. 2015. CDC/NHSN surveillance definitions for specific types of infections. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef-current.pdf.
24. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233-2239.
25. Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv:1303.3997.
26. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA. 2010. The Genome Analysis Toolkit: a MapReduce framework for analyzing nextgeneration DNA sequencing data. Genome Res 20:1297-1303. http://dx.doi.org/10.1101/gr.107524.110.
27. Wood DE, Salzberg SL. 2014. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol 15:R46. http://dx.doi.org/10.1186/gb-2014-15-3-r46.
28. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640-2644. http://dx.doi.org/10.1093/jac/dks261.
29. Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, Jelsbak L, Sicheritz-Pontén T, Ussery DW, Aarestrup FM, Lund O. 2012. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol 50:1355-1361. http://dx.doi.org/10.1128/JCM.06094-11.
30. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. 2010. The population structure of Acinetobacter baumannii: expanding multiresistant clones fromanancestral susceptible genetic pool. PLoS One 5:e10034. http://dx.doi.org/10.1371/journal.pone.0010034.
31. Jolley KA, Maiden MC. 2010. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11:595. http://dx.doi.org/10.1186/1471-2105-11-595.
32. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. 2004. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 186:1518-1530. http://dx.doi.org/10.1128/JB.186.5.1518-1530.2004.
33. Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA, Bentley SD, Parkhill J, Harris SR. 2015. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res 43:e15. http://dx.doi.org/10.1093/nar/gku1196.
34. Stamatakis A. 2006. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousandsoftaxa and mixed models. Bioinformatics 22:2688-2690. http://dx.doi.org/10.1093/bioinformatics/btl446.
35. Schliep KP. 2011. phangorn: phylogenetic analysis in R. Bioinformatics 27:592-593.
36. Paradis E, Claude J, Strimmer K. 2004. APE: analyses of phylogenetics and evolution in R language. Bioinformatics 20:289-290. http://dx.doi.org/10.1093/bioinformatics/btg412.
37. Jombart T. 2008. adegenet: a R package for the multivariate analysis of genetic markers. Bioinformatics 24:1403-1405. http://dx.doi.org/10.1093/bioinformatics/btn129.
38. Jombart T, Cori A, Didelot X, Cauchemez S, Fraser C, Ferguson N. 2014. Bayesian reconstruction of disease outbreaks by combining epidemiologic and genomic data. PLoS Comput Biol 10:e1003457. http://dx.doi.org/10.1371/journal.pcbi.1003457.
39. Pfeifer B, Wittelsbürger U, Ramos-Onsins SE, Lercher MJ. 2014. PopGenome: an efficient Swiss army knife for population genomic analyses in R. Mol Biol Evol 31:1929-1936.
40. Gu Z, Gu L, Eils R, Schlesner M, Brors B. 2014. circlize implements and enhances circular visualization in R. Bioinformatics 30:2811-2812.
41. Mugnier PD, Poirel L, Naas T, Nordmann P. 2010. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 16:35-40.
42. Roberts SA, Findlay R, Lang SDR. 2001. Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit. JHosp Infect 48:228-232. http://dx.doi.org/10.1053/jhin. 2001.0985.
43. Simor AE, Lee M, Vearncombe M, Jones-Paul L, Barry C, Gomez M, Fish JS, Cartotto RC, Palmer R, Louie M. 2002. An outbreak of due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol 23:261-267. http://dx.doi.org/10.1086/502046.
44. Bayat A, Shaaban H, Dodgson A, Dunn KW. 2003. Implications for burns unit design following an outbreak of multi-resistant Acinetobacter infection in ICU and burns unit. Burns 29:303-306. http://dx.doi.org/10.1016/S0305-4179 (03) 00011-1.
45. Zanetti G, Blanc DS, Federli I, Raffoul W, Petignat C, Maravic P, Francioli P, Berger MM. 2007. Importation of Acinetobacter baumannii into a burn unit: a recurrent outbreak of infection associated with widespread environmental contamination. Infect Control Hosp Epidemiol 28:723-725. http://dx.doi.org/10.1086/517956.
46. Marchaim D, Navon-Venezia S, Schwartz D, Tarabeia J, Fefer I, Schwaber MJ, Carmeli Y. 2007. Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol 45:1551-1555. http://dx.doi.org/10.1128/JCM.02424-06.
47. Jadad A, Siefert H, Snelling AM, Heritage J, Hawkey PM. 1998. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 36:1938-1941.
48. Alshahni MM, Asahara M, Kawakami S, Fujisaki R, Matsunaga N, Furukawa T, Teramoto T, Makimura K. 2015. Genotyping of Acinetobacter baumannii strains isolated at a Japanese hospital over five years using targeted next-generation sequencing. J Infect Chemother 21:512-515. http://dx.doi.org/10.1016/j.jiac.2015.03.009.
49. Snitkin ES, Zelazny AM, Montero CI, Stock F, Mijares L, NISC Comparative Sequence Program, Murray PR, Segre JA. 2011. Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii. Proc Natl Acad Sci U S A 108:13758-13763. http://dx.doi.org/10.1073/pnas.1104404108.
50. Wright MS, Haft DH, Harkins DM, Perez F, Hujer KM, Bajaksouzian S, Benard MF, Jacobs MR, Bonomo RA, Adams MD. 2014. New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis. mBio 5(1):e00963-13. http://dx.doi.org/10.1128/mBio.00963-13.
51. Adams MD, Goglin K, Molyneaux N, Hujer KM, Lavender H, Jamison JJ, MacDonald IJ, Martin KM, Russo T, Campagnari AA, Hujer AM, Bonomo RA, Gill SR. 2008. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol 190:8053-8064. http://dx.doi.org/10.1128/JB.00834-08.
52. Wen H, Wang K, Liu Y, Tay M, Lauro FM, Huang H, Wu H, Liang H, Ding Y, Givskov M, Chen Y, Yang L. 2014. Population dynamics of an Acinetobacter baumannii clonal complex during colonization of patients. J Clin Microbiol 52:3200-3208. http://dx.doi.org/10.1128/JCM.00921-14.
53. Adams-Haduch JM, Onuoha EO, Bogdanovich T, Tian GB, Marschall J, Urban CM, Spellberg BJ, Rhee D, Halstead DC, Pasculle AW, Doi Y. 2011. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J Clin Microbiol 49:3849-3854. http://dx.doi.org/10.1128/JCM.00619-11.
54. Jones CL, Clancy M, Honnold C, Singh S, Snesrud E, Onmus-Leone F, McGann P, Ong AC, Kwak Y, Waterman P, Zurawski DV, Clifford RJ, Lesho E. 2015. A fatal outbreak of an emerging clone of extensively drugresistant Acinetobacter baumannii with enhanced virulence. Clin Infect Dis 61:145-154. http://dx.doi.org/10.1093/cid/civ225.
55. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. CLSI M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.